![Rob Slack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rob Slack
Teknisk/Vetenskaplig/F&U Direktör på
VICORE PHARMA HOLDING AB
Profil
Rob Slack is currently Chief Scientific Officer at Vicore Pharma Holding AB since 2026.
Formerly, Dr. Slack was Vice President & Head-Respiratory Biology at GSK Plc and Chief Scientific Officer at Damora Therapeutics, Inc. Dr. Slack earned a doctorate from the University of Strathclyde.
Aktiva positioner av Rob Slack
| Företag | Position | Start |
|---|---|---|
| VICORE PHARMA HOLDING AB | Teknisk/Vetenskaplig/F&U Direktör | 2026-07-06 |
Tidigare kända positioner av Rob Slack
| Företag | Position | Slut |
|---|---|---|
| GSK PLC | Företagsledare/Principal | - |
| DAMORA THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Rob Slacks utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
5
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Strathclyde
 University of Strathclyde Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vicore Pharma Holding AB
 Vicore Pharma Holding AB Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for lung diseases | Health Technology |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
![\"G](\"https://www.zonebourse.com/images/ImagesTagged/GD/2026/google/Google__G__logo.svg\"){kind=logo}
Välj MarketScreener 
